Neuropsychiatric Symptoms and Psychotropic Medication Use Following SARS-Cov-2 Infection Among Elderly Residents in Long-Term Care Facilities
Both acute and short-term neuropsychiatric symptoms associated with COVID-19 may contribute to long-term psychoactive polypharmacy among older adults living in long-term facilities.
Authors
- Diana Cruz-Santiago
- Michelle Canac‐Marquis (ORCID: https://orcid.org/0000-0002-2895-4514)
- Xiangfei Meng (ORCID: https://orcid.org/0000-0002-0857-1305)
- Hélène Girouard (ORCID: https://orcid.org/0000-0001-8972-8433)
- Jean-Philippe Brassard
- Avik Sengupta
- Jean‐Philippe Gouin (ORCID: https://orcid.org/0000-0002-5497-5140)
- Donald C. Vinh (ORCID: https://orcid.org/0000-0003-1347-7767)
- Erik Pavey
Institutions
- Douglas College (CA)
- Douglas Mental Health University Institute (CA)
- McGill University Health Centre (CA)
- Concordia University (US)
- McGill University (CA)
- Concordia University (CA)
- Université de Montréal (CA)
Publication Details
- Journal
- Canadian Geriatrics Journal
- Published
- 2025-03-05
- DOI
- https://doi.org/10.5770/cgj.28.770
- Primary Topic
- Long-Term Effects of COVID-19
- Type
- article
- Field-Weighted Citation Impact
- 0.00